QA1.791BillableNew this fiscal year
Familial cancer syndrome with pathogenic BRCA2 mutation
- Chapter
- —
- Category
- QA1
- Effective date
- October 1, 2026
Related codes in category QA1
QA1Genetic disorders associated with neoplasms, NECQA1.7Inherited neoplasm predisposition synd w mult systems, NECQA1.71Lynch syndromeYesQA1.79Other inherited neoplm predisposition synd of mult systemsQA1.790Familial cancer syndrome with pathogenic BRCA1 mutationYesQA1.792Li Fraumeni syndromeYesQA1.798Other inherited neoplm predisposition synd of mult systemsYes
Frequently asked questions
What is ICD-10 code QA1.791?
QA1.791 is an ICD-10-CM diagnosis code for Familial cancer syndrome with pathogenic BRCA2 mutation.
Is QA1.791 a billable code?
Yes. QA1.791 is billable and specific enough to be used on a claim.
When did QA1.791 become effective?
QA1.791 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to QA1.791?
QA1.791 belongs to category QA1, which includes 7 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.